We examined the role of extracellular calcium entry, the possible involvement of axonal calcium channels, and the potential protective effect of calcium channel and calpain antagonists in axotomy-induced axonal degeneration using murine dorsal root ganglia in cell culture. We found that calcium entry is both necessary and sufficient to induce axonal degeneration after axotomy, and may be inhibited by cobalt, manganese, dihydropyridines, and bepridil.
Tetrodotoxin and ti-conotoxin are ineffective in preventing axonal degeneration.
The activation of calpains also appears to be necessary and sufficient for axonal degeneration to proceed, and can be blocked with membrane-permeant leupeptin analogs and the oxirane aloxistatin. Although other calcium-activated events may occur, it appears that inhibition of calpain is sufficient to preserve the axon at the light microscope level, and to prevent axonal cytoskeleton degradation as detected by immunofluorescent staining.
Our results suggest that axonal degeneration after axotomy involves the following sequence of events: (1) a lagperiod after axotomy prior to the onset of axonal degeneration, (2) entry of calcium into the axon through an intact axolemma via a calcium-specific ion transport mechanism, (3) activation of calcium-dependent effector molecules such as calpains, (4) degradation of the axonal cytoskeleton. The details of the second step require further elucidation, and are of particular interest because this step is a potential target for therapies directed towards peripheral neuropathies.
[ Nerve fibers require continuity with the nerve cell body for their survival. This principle, implicit in Waller's observation that the distal stumps of transected nerve fibers degenerate, was one of the fundamental discoveries in nineteenth century neurobiology (Waller, 1850) . The recognition 100 years later that most neuronal proteins are synthesized in the neuronal perikaryon and carried to the axon by specialized axonal transport systems led to the attractive presumption that degeneration of the transected axon was due to its disconnection from the cell body, resulting in a form of intracellular "starvation" for necessary proteins and other materials. While this may be the case in some species (Cancalon and Elam, 1980; Cancalon, 1983a,b) , reassessment of the basis for degeneration of the transected mammalian nerve fiber (Wallerian degeneration) is mandated by the recent discovery of a mutant mouse substrain, the C57/Bl/Ola (Ola) mouse, whose axons survive for as long as a month after transection (Lunn et al., 1989; Glass and Griffin, 1991; Brown et al., 1994; Tsao et al., 1994) . The prolonged survival of transected Ola axons demonstrates that a general depletion of materials carried by axonal transport cannot be the cause of axonal degeneration in normal axons, which degenerate within a few days of transection. Instead, it appears that a specific mechanism must be present in normal axons, but not in Ola axons, which leads to prompt axonal degeneration once continuity with the cell body is lost. Since Ola mice are otherwise normal, it appears that it is possible to prevent the normal mechanism of prompt axonal degeneration without greatly perturbing the other properties of the neuron.
The existence of an axonal degeneration mechanism that can both be triggered by certain events and be specifically blocked carries profound implications for the physiology and pathophysiology of axons. Axonal degeneration is an important step in allowing for subsequent regeneration after axon injury. Degeneration of unwanted axons and pruning of axonal arborizations is a key element during nervous system development. Axonal degeneration is a common process in a wide variety of metabolic, toxic, hereditary, and inflammatory disorders. The morphology of axonal degeneration is very similar in all these circumstances, and the existence of a specific mechanism for axonal degeneration suggests that there may be common elements in the axonal degeneration which occur in each of these cases.
The simplest model of axonal degeneration remains Wallerian degeneration produced by nerve transection. Studies in the 1970s demonstrated that severed axons maintained in EGTA degenerated more slowly than those in high-calcium media, and implicated the action of axonal calcium-dependent proteases (calpains), which were demonstrated to cleave the major axonal proteins (Schlaepfer and Bunge, 1973; Schlaepfer, 1974; Schlaepfer and Micko, 1978; Schlaepfer and Hasler, 1979; Schlaepfer and Zimmerman, 1984; Schlaepfer et al., 1985) . Proteolytic activity appears to lead to granular disintegration of the axoplasm, the first morphologically detectable change in an axon undergoing axonal degeneration. The mechanism by which axonal calcium levels might increase sufficiently to trigger granular disintegration of the axon has not been established. Using murine dorsal root ganglia in cell culture, we examined the role of Axonal Degeneration Is Mediated by Calcium extracellular calcium entry, the possible involvement of axonal calcium channels, and the potential protective effect of calcium channel and calpain antagonists.
Materials and Methods
The typical experiment involved the following steps. Dorsal root ganglion neurons were allowed to extend axons in culture. The axons were subsequently severed near the cell body, and the distal axon was allowed to degenerate for 4 d. The degenerating axons were subjected to various pharmacologic treatments during this period, and then the extent of axonal degeneration was determined at the end of the 4 d period. The degenerating axons were subsequently fixed and prepared for immunostaining.
Dorsal root ganglion cultures. The dorsal root ganglia were dissected from mouse pups during the first two days of life. Whole ganglia explants were cultured in collagen-coated 35 mm dishes (Falcon) using N2 medium (Dulbecco's Modified Eagle medium and Ham's F12 medium (GIBCG) mixed 1:l and supplemented with progesterone, selenium. insulin. nutrescine. glucose, 7s NGE and nenicillin-streptomvtin) at 37°C in a 5% CO;environment (Bottenstkin and Sate,-1979) . Axons grew outwards from the ganglia, producing a neuritic halo. Ganglia were cultured for 10-15 d prior to experiments in order to obtain sufficient axon growth.
Materials. Media with reduced calcium concentrations were prepared from oowdered denleted Dulbecco's Modified Eagle/Ham's F12 medium (Sigma) supplemented with the usual amounts-of all depleted components except for CaCI,, which was added to the desired concentration of calcium, and additional MgCl, to keep the sum of the calcium and magnesium concentrations constant. The free [Cal+] in reduced calcium and in EGTA containing media was determined using a calcium-specific electrode (Orion). EGTA, nifedipine, and aloxistatin were obtained from Sigma. Calpain inhibitor I, calpain inhibitor II, o-conotoxin GVIA, and bepridil were obtained from CalBiochem. The antibodies other than anti-B-tubulin (Sigma), PGP9.5 (Accurate) and anti-neurofilament (Sternberger Monoclonals) were purchased from Molecular Probes. The ionophores A23187 and ionomycin were purchased from Molecular Probes. Nimodipine was the gift of Alexander Scriabine (Miles).
Axotomy-induced uxonal degeneration. Using a microscalpel, cuts were made through the neuritic halo around each ganglion and the ganglion was removed, leaving the severed axons in the culture dish. Excision of the ganglia prevents axons from regenerating into the region occupied by the degenerating axons. Within 30 min after axotomy the culture medium was exchanged with media containing the desired pharmacologic agents, or in some cases with media with a reduced calcium concentration.
Axonal degeneration occurred over a period of several days after axotomy. In control cultures, the severed axons appeared normal for 12-24 hr after axotomy, then developed focal swellings or beads. In most cases, the axons completely degenerated by 48-60 hr, leaving little or no axonal debris. Some transected axons took as long as 72-84 hr to completely degenerate. To allow for complete degeneration to occur, the effects of various treatments were assessed by comparison to control cultures at 96 hr after axotomy.
Data analysis. Four days after axotomy, the cultures were examined under a phase-contrast microscope (Olympus IMT-2). Each ganglion excision (axotomy) site was evaluated for the presence of surviving axons. Axons with a normal appearance and axons with a beaded appearance were scored as having survived. Discontinuous fragments of what appeared to have been an axon were considered to be debris, and the axon was scored as degenerated. Each ganglion excision site was scored as either having surviving axons or not. For each experiment, the fraction of ganglion sites with surviving axons was calculated and the binomial standard deviation determined.
This approach gives an "all or nothing" score to each ganglion explant. In doing so it eliminates most observer bias, by asking for each ganglion explant "Are there any remaining axons which meet the simple morphologic criteria for preservation?" The abundance of the preserved axons (which varies with the abundance of axons prior to axotomy) and the vitality of the preserved axons need not be judged by the observer, although these subjective impressions do seem to correlate with the fraction of ganglion sites which have surviving axons. The measure is relatively insensitive to degeneration of some but not all axons: if all ganglia lose 50% of their axons, we would still score 100% survival. There is, however, considerable ganglion-to-ganglion variation Figure 1 . Axons in a murine dorsal root ganglia culture 4 d after axotomy, kept in media with EGTA. The culture medium was exchanged within 30 min after axotomy with media containing 2 mM EGTA. Free [Ca*+] in the media was cl.0 ~J,M as determined by calcium-specific electrode. The axons develop some beading, which is clearly seen along individual axons and small fascicles (small urrowheads). The beading of the individual axons creates a "grainy" appearance in the large fascicles (large arrowheads). Low calcium concentrations cause non-neuronal cells to lose their adherence to the substratum, and develop a rounded, swollen appearance and increased brightness in these phase-contrast micrographs. One such cell is designated by the small arrow, while a cluster of cells is marked with an asterisk. Scale bar, 25 pm.
in the abundance and vigor of the axon outgrowth under the best of conditions, and conditions which lead to a noticeable reduction in axon survival among the most luxuriant ganglia generally produce a greater percentage of ganglia with no surviving axons.
Zmmunohistochemistry. Cultures to be immunostained were fixed with 4% formaldehyde in the culture dish for one hour. The cultures were washed with phosphate buffer, then exposed to primary antibody for at least 1 hr, washed again, and incubated with FITC-conjugated (1: 25) or Texas red-conjugated (1:lOO) secondary antibody for at least 1 hr. Primary antibodies used included anti-P-tubulin (1: loo), anti-neurofilament ( 1: lOOO), and anti-PGP9.5 ( 1:500). BODIPY-phalloidin (1: 100) was used to stain cultures for actin. Cultures were fixed as described and then exposed to BODIPY-phalloidin for 1 hr. The immunostained cultures were observed and photographed under phase-contrast and epifluorescence using the Olympus IMT-2 microscope.
Results
External calcium is required for axonal degeneration When the neurites elaborated by cultured murine dorsal root ganglia are transected (axotomy), the severed axons appear normal for 12-24 hr, then develop focal swellings or beads. In most cases, the axons completely degenerate by 48-60 hr, leaving little or no axonal debris. Some transected axons take as long as 72-84 hr to completely degenerate. When extracellular calcium levels are reduced by adding EGTA to the culture media after axotomy, the axons develop a beaded appearance but fail to degenerate within a week after axotomy (Fig. 1) . When additional calcium is added to maintain normal free calcium concentrations in the presence of EGTA, axonal degeneration proceeds.
Axonal degeneration is also delayed when axotomized axons are exposed to media with a reduced calcium content. To reliably attain calcium concentrations less than 100 pM, EGTA must be added to the culture media to buffer the calcium concentration from variations due to the small amounts of calcium in the water and culture reagents. For concentrations above 100 pM, media without added calcium is prepared and the required amount of calcium is added. The actual concentration of free calcium in each culture is determined using an ion specific electrode. When extracellular calcium is reduced below 200 pM, the axotomized axons fail to degenerate for at least 4 d (Fig. 2) .
Calcium entry is suficient to produce axonal degeneration An increase in the intra-axonal calcium concentration is capable of producing axonal degeneration which appears identical to the degeneration produced by axotomy. Elevations of intra-axonal calcium can be produced with calcium ionophores. Both A23 187 and ionomycin produce degeneration of uncut axons when added to dorsal root ganglia cultures (Fig. 3) . Ionophores are added to both uncut and axotomized cultures at 20 nM. Axonal degeneration is evident by light microscopy within 30 min after ionophore addition, and axons are completely disrupted by 1 hr, although identifiable axonal debris persists. Rapid degeneration of cut axons is produced when the ionophore is added within 24 hr of axotomy, indicating that the neuronal cell body is not involved in the axonal response to ionophores. Simultaneous addition of EGTA prevents the axonal degeneration induced by ionophores, confirming that it is a calcium dependent process.
Calcium channel blockers prevent axonal degeneration
Cobalt and manganese are non-specific calcium channel inhibitors: these metal ions prevent calcium entry by their ability to enter and be bound within calcium-specific channels. Both cobalt and manganese are effective in delaying axonal degeneration after axotomy. Figure 4 shows the dose-response relation for preservation of axotomized axons by cobalt and manganese. Cobalt has a lower EC,, than is seen with manganese. Addition of the calcium ionophore A23 187 in the presence of 1 mu cobalt results in rapid axonal degeneration, confirming that the effect of cobalt appears to be due to prevention of calcium entry via an ion-specific channel.
Two dihydropyridine calcium channel antagonists, nifedipine and nimodipine, delay axonal degeneration after axotomy in a dose dependent fashion (Fig. 5) . The EC,, values were 9.5 and 13.7 p.M, respectively. These agents are known to block highthreshold noninactivating (L-type) calcium channels. The effective inhibitory concentrations we observed are slightly higher than those reported for neuronal L-channels in electrophysiologic experiments (Kostyuk, 1992) . This may reflect a requirement for a high degree of channel blockade in order to prevent calcium accumulation in the axons over the time course of our experiments.
Conotoxin does not block axonal degeneration w-Conotoxin GVIA is a peptide toxin purified from the venom of cone snails. w-Conotoxin GVIA blocks high-threshold inactivating (N-type) calcium channels in chick dorsal root ganglion, rat sympathetic cells and PC12 cells (Kasai et al., 1987; Olivera et al., 1987; Plummer et al., 1989; Hess, 1990) . w-Conotoxin GVIA does not inhibit axonal degeneration in our cultures even at very high concentrations (up to 10 nM). This suggests that calcium enters primarily through channels other than N-type calcium channels during axonal degeneration.
Bepridil blocks axonal degeneration
In addition to blocking sodium-and calcium-specific ion channels, bepridil blocks the sodium-calcium exchanger (Braun et al., 1992; Gill et al., 1992; Kostyuk, 1992) . By blocking the sodium-calcium exchanger, bepridil normally should act to enhance calcium accumulation, although under certain circumstances, discussed in more detail below, the sodium-calcium exchanger may promote calcium entry, and bepridil would have the opposite effect. If the primary cause of the rise in intracellular calcium were failure to extrude or sequester intracellular calcium, and not an influx of calcium through calcium specific channels, bepridil would be expected to promote axonal degeneration. Bepridil prevents axonal degeneration at low concentrations, but the inhibition of axonal degeneration gradually decreases with increasing concentration (Fig. 6 ). This result is still consistent with calcium entry via ion specific channels as an important component of the increase in intra-axonal calcium, and suggests that the inhibitory effect of bepridil on the sodium- calcium exchanger becomes significant at higher concentrations, and opposes the calcium channel blocking effect.
Tetrodotoxin does not block axonal degeneration Calcium can enter cells through sodium channels, which are not perfectly ion specific. The high concentration of sodium channels in axons may thus lead to significant calcium entry through these channels. In addition, a significant sodium influx could promote calcium entry via the sodium-calcium exchanger. The sodium<alcium exchanger normally works to extrude intracellular calcium by exchanging it for extracellular sodium, which can be in turn extruded by the sodium-potassium ATPase. When intracellular sodium concentrations are high, the gradient for calcium entry may exceed the gradient for sodium entry, causing the sodium-calcium exchanger to work in reverse, allowing calcium entry and extruding intracellular sodium Waxman et al., 1991) . Thus, a high sodium influx could result in an accumulation of intra-axonal calcium. We tested this possibility by blocking sodium channels with tetrodotoxin. There is no measurable delay in axonal degeneration after axotomy (Fig.  6 ) in the presence of tetrodotoxin at concentrations up to 10 FM.
Activation of calpains during axonal degeneration
Activation of calpains is an attractive mechanism by which an increase in intra-axonal calcium could lead to axonal degeneration (Schlaepfer and Bunge, 1973; Schlaepfer, 1974; Schlaepfer and Micko, 1978; Schlaepfer and Hasler, 1979; Schlaepfer and Zimmerman, 1984; Schlaepfer et al., 1985; Xie and Barrett, 1991) . We tested the ability of two classes of calpain inhibitors to prevent axonal degeneration, the leupeptin analogs and oxiranes. Calpain Inhibitor I (N-Ac-Leu-Leu-norleucinal) and Calpain Inhibitor II (N-Ac-Leu- Leu-normethioninal) are cell-permeant leupeptin analogs. Aloxistatin is a cell permeant oxirane calpain inhibitor. All three agents preserve axotomized axons in a concentration-dependent manner, as is shown in Figure 7 . 
Integrity of preserved axons
The axolemmal and cytoskeletal integrity of axons preserved by calcium channels inhibitors was further characterized by immunostaining. Immunostaining with antibodies directed against tubulin and neurofilament confirmed staining along the length of the preserved axons (Fig. 8) , which was comparable to the staining seen in uncut control axons, indicating preservation of the axonal cytoskeleton. Neuronal ubiquitin C-terminal hydrolase is a cytosolic enzyme detected by the antibody PGP9.5. Preserved axons immunostained with PGP9.5 show levels of staining (Fig. 8) comparable to controls. This observation suggests that the axolemma is preserved in the surviving fibers, and argues against the possibility that the cytoskeletal elements might be preserved in the absence of an intact axolemma.
Discussion
Our results suggest that axotomy-induced axonal degeneration involves the following sequence of events: (1) a lag-period after axotomy prior to the onset of axonal degeneration, (2) entry of calcium into the axon through an intact axolemma via a calciumspecific ion transport mechanism, (3) activation of calcium-dependent effector molecules such as calpains, (4) degradation of the axonal cytoskeleton. The later steps are potentially common to all axonal degeneration, but other triggers of axonal degeneration may involve alternate entry points into this final common pathway. While our observations are made on cultured neurons, the observed lag-period and the subsequent time course of axonal degeneration are quite consistent with observations of axonal degeneration in vivo (Chaudhry and Comblath, 1992; . The morphology of the degenerating cultured axons is also identical to in vivo axonal degeneration, as is consistent with the fact that these primary explant cultures produce neurites whose composition and fine structure are quite representative of axons in vivo ( 1978; Bray and Bunge, 1981) . We suggest that the sequence of events observed in these degenerating cultured axons is a model for axonal degeneration in vivo.
The lag-period In our cultures, there is no evidence of axonal degeneration in most axons for 12-24 hr after axotomy. This is consistent with the established ability of severed axons to quickly reseal and maintain internal homeostasis (Xie and Barrett, 1991; Ziv and Spira, 1993) , and also consistent with the time course in vivo. This delay can vary between species, being typically 24-48 hr in rats and mice but as long as 7 d in humans, and also seems to vary with the length of axon distal to the transection (Chaudhry and Cornblath, 1992; . Some event during this period triggers the subsequent accumulation of intraaxonal calcium, and it seems likely that this event is tied to axonal transport (Lubinska, 1977) . This event may fail to occur in the Ola mutant, since increased axonal calcium produces degeneration of cultured Ola axons and calpain activity can be demonstrated in Ola axons (Glass et al., 1994) .
Entry of calcium into the axon Schlaepfer et al. (Schlaepfer and Bunge, 1973; Schlaepfer, 1974; Schlaepfer and Micko, 1978) demonstrated previously that a rise in intra-axonal calcium is associated with axonal degeneration. Our data show clearly that entry of extra-axonal calcium is a necessary component, as axonal degeneration did not proceed if the extra-axonal calcium concentration was below 200 PM. This is considerably greater than the normal cytosolic calcium concentration, and maintenance of the extra-axonal calcium concen- tration in this range did not require the presence of a calcium chelator, making it unlikely that depletion of intra-axonal calcium stores played a role in the inhibition of axonal degeneration. It remains possible that additional, calcium is released from axonal stores subsequent to the entry of the extra-axonal calcium. Nonetheless, it is important to note that the requirement for an extra-axonal calcium concentration 2200 p,M correlates well with the reported activation of m-calpain at calcium concentrations above 200 PM (Mehdi, 1991) . The inhibition of axonal degeneration by cobalt and manganese, metal ions which can substitute for calcium in many processes, but which do not pass through calcium-conductive ion channels, strongly implies that calcium entry occurs through a calcium-specific ion transport mechanism. Certainly these ions should not be able to prevent calcium entry if a significant disruption of membrane integrity were the calcium entry mechanism. The lower EC,, seen with cobalt as compared to manganese is consistent with the specificity seen for binding of these ions to calcium-specific channels. It is unlikely that the inhibition of axotomy-induced axonal degeneration is due to competition with calcium at an intra-axonal site: these ions do not interfere with calcium activation of calpains, and in fact manganese can also activate calpains (Zimmerman and Schlaepfer, 1982; Mehdi, 1991) . Moreover, when the ionophore A23187 is added to cultures in the presence of both inhibitory concentrations of cobalt and normal levels of extra-axonal calcium, rapid axonal degeneration occurs, confirming that these ions do not interfere with the intra-axonal mechanisms activated by calcium entry.
The effectiveness of dihydropyridines in preventing axonal degeneration also points to the involvement of an ion-specific channel. Dihydropyridines are known inhibitors of L-type calcium channels, although at high concentrations they may interfere with other types of calcium channels. L-Type calcium channels have been demonstrated on dorsal root ganglion cell bodies (Nowycky et al., 198.5; Fox et al., 1987; Plummer et al., 1989; Kostyuk, 1992) , but were not thought to be present in the axons. Recent evidence in other species, however, suggests that axonal calcium channels may be common, and in fact may be L-type channels (DiPolo et al., 1983; Lipscombe et al., 1988; Ziv and Spira, 1993) .
L-Type calcium channels are voltage-gated channels, but the role of depolarization in the calcium entry during axotomy-induced axonal degeneration has not yet been investigated. Previous studies have demonstrated that there is a transient depolarization and increase in intra-axonal calcium immediately after transection, which quickly normalize once the axolemma reseals (Xie and Barrett, 1991; Ziv and Spira, 1993) . The subsequent calcium entry associated with axonal degeneration does not occur until at least 24 hr later. The transient changes seen immediately after transection are similar in both the axonal stump, which will not degenerate, and the isolated segment, which will go on to degenerate. Since axonal degeneration requires extra-axonal calcium levels 2200 PM, if calcium entry is driven solely by the concentration gradient, intracellular calcium concentrations of 2200 FM would be needed to produce axonal degeneration. If a normal resting potential of -60 mV were present, then an extracellular concentration of 2200 pM would equilibrate with an intracellular calcium concentration of 22 mu. As noted previously, a requirement for a calcium concentration 2200 FM correlates well with the reported activation of m-calpain at calcium concentrations above 200 FM (Mehdi, 1991) , while a requirement for 22 DIM calcium does not appear consistent with the permeabilization data. This suggests that calcium equilibrates across a depolarized membrane, as is consistent with the involvement of a voltage-gated channels.
The failure of w-conotoxin GVIA to inhibit axonal degeneration suggests that N-type calcium channels are not required. N-Type calcium channels have also been demonstrated on dorsal root ganglion cell bodies (Nowycky et al., 1985; Fox et al., 1987; Kasai et al., 1987; Olivera et al., 1987) , and are thought to traverse the axon and participate in presynaptic vesicle release. T-type calcium channels have also been demonstrated on dorsal root ganglion cell bodies (Nowycky et al., 1985; Fox et al., 1987; Plummer et al., 1989; Kostyuk, 1992) , and the involvement of ligand-gated calcium channels is also a possibility. None of these other channels are sensitive to micromolar concentrations of dihydropyridines, as is the L-type channel.
A further possibility is the indirect involvement of sodium channels. Waxman and coworkers have shown that axonal degeneration in central nervous system axons after ischemia involves calcium entry via the sodium-calcium exchanger Waxman et al., 1991) . These axons become sodiumloaded during the prolonged depolarization associated with ischemia. The lack of a sodium concentration gradient across the membrane, in the presence of a calcium concentration gradient, causes the sodium-calcium exchanger to be driven in reverse, resulting in calcium entry. This process is inhibited in ischemic optic axons by both tetrodotoxin (TTX), which prevents sodium loading, and bepridil, which can inhibit the sodium-calcium exchanger.
Bepridil is inhibitory at low concentrations in our system. Unfortunately, bepridil, like the amiloride derivatives, is a potent nonspecific calcium channel inhibitor (Kleyman and Cragoe, 1988; Braun et al., 1992; Gill et al., 1992) as well as an inhibitor of the sodium-calcium exchanger. This renders these compounds ineffective for discriminating between the "calcium channel" hypothesis and the "reversed sodium-calcium exchanger" hypothesis. Bepridil becomes less effective with increasing concentration in our system, which may reflect its ability to inhibit both calcium channels and the sodium-calcium exchanger. Thus, at low doses blockade of calcium channels may be the dominant effect, while at higher doses the inhibition of the sodium-calcium exchanger, which is normally important for calcium extrusion, may contribute to a rise in intra-axonal calcium concentrations.
TTX is ineffective as an inhibitor of axonal degeneration in our system. This may indicate that sodium loading is not involved in axonal degeneration after axotomy. TTX-resistant sodium channels are found on immature dorsal root ganglion cells, however, making the inefficacy of TTX inconclusive. TTX-resistant sodium channels are known to be blocked by cobalt, manganese, and phenylalkylamines (Baker et al., 1973; Kostyuk et al., 1981) , but are not known to be sensitive to dihydropyridines.
Activation of calpains
Once calcium enters the axon, it is thought to activate calpains (Schlaepfer and Bunge, 1973; Schlaepfer, 1974; Schlaepfer and Micko, 1978; Schlaepfer and Hasler, 1979; Schlaepfer and Zimmerman, 1984; Schlaepfer et al., 198 .Q which degrade the axonal cytoskeleton, although it is possible that other calcium-dependent processes are also activated. Both the membrane permeant leupeptin analogs, calpain inhibitors I and II, and the oxirane, aloxistatin, were effective inhibitors of axonal degeneration in our system. Since the leupeptin analogs are structurally dissimilar from the oxiranes, it seems probable that their common mechanism is inhibition of calpains. In addition, as noted above, the calcium dependence of axonal degeneration in our system is similar to the calcium dependence of m-calpain. Although other calcium-activated events may occur, it appears that inhibition of calpain is sufficient to preserve the axon at the light microscope level, and prevent axonal cytoskeleton degradation as detected by immunofluorescent staining.
Conclusions
Calcium entry via an ion-specific mechanism is an early step in axonal degeneration which subsequently leads to activation of calpains. Calcium entry is both necessary and sufficient to induce axonal degeneration after axotomy, and may activate axonal degeneration under other circumstances. The activation of calpains also appears necessary and sufficient for axonal degeneration to proceed, although the role of other calcium activated processes needs to be further investigated. The mechanism by which calcium entry is initiated after a latent period of one or more days remains to be elucidated. This mechanism is probably deficient in the Ola mutant mouse, and is a potential target for therapies directed towards peripheral neuropathies.
